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We investigated the role of sensory nerves in glucose tolerance in conscious Wistar rats neonatally treated with
neurotoxin capsaicin or vehicle. Intravenous glucose tolerance tests (IVGTT, 150, 300 and 450 mg in 30 min) were
performed to measure glucose tolerance, and glucose, insulin and glucagon levels were measured.
Higher glucose concentration resulted in a greater insulin response in both capsaicin- and vehicle-treated rats.
However, glucose-stimulated insulin secretion was attenuated in capsaicin-treated animals, even though glucose
levels did not differ. Glucagon levels did not differ between both groups. These results show that capsaicin-
sensitive nerves are involved in glucose-stimulated insulin secretion, but are not directly involved in the regulation
of blood glucose levels. Moreover, they suggest that capsaicin-sensitive nerves could be involved in the regulation
of insulin sensitivity. We hypothesize that sensory afferents could play a role in the aetiology of pathologies where
glucohomeostatic mechanisms are disturbed, as is in type 2 diabetes mellitus.
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Insulin secretion is regulated by both autonomic nerves and by humoral factors. This is reflected by
the rich innervation of pancreatic islets by parasympathetic, sympathetic and sensory nerves (Ahren,
2000). Classical neurotransmitters harboured in cholinergic and adrenergic nerves are important for the
control of islet hormone secretion and therefore for controlling glucose homeostasis (Shimazu, 1996;
Ahren et al., 1986, 1997; Kvist-Reimer et al., 2002). The brain appears crucial for coordinating an
adequate response to glucose load, hypoglycemia and exercise. However, ample evidence suggests that
peripheral loci are also important in the initiation of such a response. Little information exists regarding
the relative involvement of these peripheral primary afferents in glucose homeostatic regulatory
mechanisms, despite the fact that the entire gastro-intestinal tract—including important glucose-sensing
organs such as liver and pancreas—is innervated by vagal afferents (Berthoud and Neuhuber, 2000). The
importance of sensory (afferent) nerves, as Ay and C-fibers, in the control of glucose homeostasis has
been shown in a number of studies. Although their exact function is not yet established, it appears that
after treatment with the neurotoxin capsaicin, which destroys small unmyelinated fibers (Holzer, 1991),
animals show an improved glucose tolerance accompanied with an increased early insulin response after
an intravenous glucose injection (Karlsson et al., 1994). This improved glucose tolerance after capsaicin
treatment was also seen during an oral glucose tolerance test, although the insulin response was not
affected (Guillot et al., 1996). These results could indicate that capsaicin-sensitive sensory nerves are
involved in the regulation of insulin sensitivity. Supporting evidence was obtained by Zhou et al. (1990)
and Koopmans et al. (1998), who found strong indications that neonatal capsaicin treatment leads to
improved insulin sensitivity. However, so far the mechanism responsible for these effects remains
unclear. Calcitonin gene-related peptide (CGRP), the main neuropeptide present in capsaicin-sensitive
nerves, affects islet hormone secretion by antagonizing the effect of insulin in vitro (Pettersson and
Ahren, 1990) as well as in vivo (Pettersson et al., 1986; Leighton et al., 1989; Choi et al., 1991). This
might explain the observed effects on insulin sensitivity after capsaicin treatment. Modulation by
sensory nerves can be due to a local effector loop, but can also be mediated via afferent vagal glucose
sensors present in the portal liver system. These are responsible for reflex modulation of efferent
pancreatic vagus nerve activity, which can be abolished by hepatic vagotomy (Okazaki et al., 1993).
The improved glucose tolerance after capsaicin deafferentation might be mediated by glucagon.
Insulin and glucagon are considered to be the key regulatory hormones for glucose homeostasis (Jiang
and Zhang, 2003). The absolute level of glucagon or the ratio of glucagon to insulin is often elevated in
various forms of diabetes in both animal and human subjects (Burcelin et al., 1996; Unger, 1985). This
indicates that glucagon plays a major role in the regulation of glucose homeostasis. Because of a lack of
afferent input, capsaicin-treated animals might exhibit a modified efferent output, and therefore, an
altered basal glucagon secretion in comparison with vehicle-treated animals. Despite evidence that
capsaicin-sensitive sensory nerve fibers are involved in the regulation of insulin sensitivity, neither their
importance in the detection of glucose, nor the underlying mechanisms, is fully understood. Therefore,
as part of a series experiments aimed at this problem, the present study investigated whether afferent
nerves are involved in the detection for glucose. We compared the responses of capsaicin-treated and
their vehicle controls during an intravenous infusion with 3 different glucose concentrations, over a
period of 10 min. Previous studies on intravenous glucose tolerance tests (IVGTT) in capsaicin-treated
animals used a single glucose injection. This causes a short and acute un-physiological disturbance in
glucose homeostasis and shows only the removal rate of glucose from the bloodstream. We used slow
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stress-free blood sampling in conscious animals. Thus, an intravenous glucose infusion gives more
information compared to a single intravenous glucose injection. The present design allows us to
determine whether capsaicin-treated animals are able to respond in the same fine-tuned manner as
vehicle-treated animals. In addition to glucose and insulin, we measured glucagon levels to determine
whether plasma changes in this insulin antagonistic hormone might contribute to the observed effects.Materials and methods
Animals and housing, capsaicin treatment, surgery
Housing
Twenty male Wistar rats, bred in our own laboratory were used and housed in climate-controlled
rooms (22F2 8C) under a 12 h :12 h light–dark cycle (lights on at 8:00 am). Food and water were
available ad libitum, unless otherwise specified. Capsaicin- and vehicle-treated pups grew up separately
to avoid selective maternal care—in litters of 5–9 pups, in the proportion 5–7 male, 2 female. After
weaning, at the age of 23 days, rats were individually housed in clear plexiglass cages (252530 cm).
Capsaicin treatment
Capsaicin (8-methyl-N-vallinyl 6 nonenamide, 50 mg/kg; Sigma Chemical, Netherlands) was given
neonatally (n=10) by a subcutaneous (s.c.) injection. This was done under 100% O2 conditions to avoid
hypoxia. Capsaicin was dissolved in a vehicle consisting of 10% ethanol (10%) and 5% cremophore–
0.9% sodium chloride solution (90%). Vehicle solution was injected s.c. (n=10) in control rats. Each
animal was given the same 50 Al volume, which we chose based on an average weight of the pups of 8 g.
At injection, both groups did not differ in body weight (capsaicin 7.9F0.09 g; control 7.9F0.09 g).
After treatment, body weight was measured weekly, but no significant differences were observed

















Fig. 1. Growth curve of capsaicin- and vehicle-treated animals. Black bar represents the experimental period. There are no
significant differences between capsaicin- and vehicle-treated animals.
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per group.
An eye wipe response (0.1% capsaicin solution) was done at the age of 3 months in order to test the
effectiveness of the capsaicin treatment. None of the capsaicin-treated animals responded to the test, so
all animals were included in the experiment.
Surgery
Double heart catheters were implanted bilaterally in the vena jugularis under general anaesthesia with
isoflurane/N2/O2; fynadine (0.01 ml/100 g body weight) was given s.c. as post-surgical analgesia.
Animals had at least 2 weeks of recovery before the start of experiments.
Experimental procedure and chemical determination
An intravenous glucose tolerance test (IVGTT) was performed. Each animal received an IVGTT
concentration 3 times with at least 3 days in between. All treatments were randomly assigned. All
experiments were performed in the light period between 12:00 and 1:00 pm. Animals were briefly food-
deprived for 3 h before the experiment started.
To facilitate stress-free blood sampling, animals were connected to the tubing cannula at least half
an hour before basal samples were taken. Glucose was infused during 30 min at a rate of 5, 10 or 15
mg/min, so each rat received a total glucose load of 150, 300 or 450 mg, respectively. Samples of 0.2
ml were taken at 11, 1, 1, 3, 5, 10, 15, 20, 25, 30, 40 and 50 min to measure glucose, insulin and
glucagon concentrations. Blood and plasma samples were stored at 20 8C until analysis. Blood
glucose levels were measured by Hoffman’s ferrocyanide method; plasma level of insulin, and
glucagon were measured by commercial radioimmunoassay kits (Linco Research; RI-13K, GL-32K,
respectively).
Statistical analysis
Results are expressed as meansFSEM. Repeated measurements analysis of variance (ANOVA)
followed by LSD post hoc tests were used for statistical evaluation. Testing for significant differences
were performed from the start of glucose infusion until end of infusion (0–30 min). Student’s t-tests were
used for unpaired observations. A p-value of b0.05 was considered significant.Results
Fig. 1 shows that there are no significant differences in the growth curves of capsaicin- vs. vehicle-
treated animals. Also, at start of the experiment, there were no differences in body weight between
capsaicin- and vehicle-treated animals (398F6.7 vs. 402F10.1 g, NS).
Fig. 2 shows the changes in blood glucose levels (A), insulin (B) and glucagon (C) plasma over time
during the 30 min 150, 300 and 450 mg i.v. glucose infusion. ANOVA for repeated measurements
revealed that the 150, 300 and 450 mg glucose load induced significant changes in glucose (F9, 108=
27.82; F9, 90=92.63; F9, 81=85.27, respectively, pb0.001) and insulin (F8, 96=7.39; F5, 55=5.72;
F8, 112= 32.99, respectively, pb0.001). Infusions of 150, 300 and 450 mg glucose did not induce
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Fig. 2. Changes in plasma levels of glucose (A), insulin (B) and glucagon (C) before, during and after i.v. infusion of 150, 300
and 450 mg of glucose in capsaicin- and vehicle-treated animals. *, **Indicates significant difference between capsaicin- vs.
vehicle-treated animal, p b0.05 and p b0.01, respectively.
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infusions (F9, 108=0.58; F9, 90=0.51; F9, 81=0.47, respectively, NS). Also, there were no differences in
glucose levels between capsaicin- and vehicle-treated animals during 150, 300 and 450 mg glucose
infusions (F1, 12=0.60; F1, 10=2.39; F1, 9=1.53, respectively, NS). In contrast, plasma insulin levels did
show significant effects of capsaicin treatment. Independent of the total glucose load (150, 300 and 450
mg), all capsaicin-treated rats had a significantly lower insulin response compared to their vehicle
controls (F1, 12=7.26; F1, 11=6.22; F1, 14=5.62, respectively, pb0.05). The early insulin response did
not differ significantly between vehicle- and capsaicin-treated animals when the amounts of 450 mg
(6.52F1.22 vs. 5.92F0.63 ng/ml, respectively, NS), 300 (5.08F0.32 vs. 5.93F1.03 ng/ml, NS) or
150 mg (4.25F2.29 vs. 3.35F0.24 ng/ml, respectively, NS) were infused. The differences between
capsaicin- and vehicle-treated animals are particularly clear in the second phase of the insulin response.
There was also no significant timegroup interaction for insulin levels during the 150 and 300 mg
Table 1
Basal values of glucose, insulin and glucagon before the start of infusion of 150, 300 and 450 mg glucose
Infusion Glucose (mM) Insulin (ng/ml) Glucagon (pg/ml)
Vehicle Capsaicin Vehicle Capsaicin Vehicle Capsaicin
5 mg/ml 5.3F0.11 5.2F0.14 2.9F2.24 2.5F0.22 75.4F9.68 84.7F6.84
10 mg/ml 5.1F0.13 4.6F0.09** 2.7F0.27 2.0F0.21 90.8F5.03 123.1F10.76
15 mg/ml 5.5F0.27 5.8F0.15 2.7F0.11 2.5F0.36 80.7F4.11 94.9F7.3
Values are averagesFSEM. Basal values are the average of basal measurements 11 and 1 min before start of the infusion.
** Significant difference between capsaicin- vs. vehicle-treated animals (2-tailed t-test; p b0.01).
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did result in significant timegroup interaction for insulin plasma levels (F1, 112=2.79, pb0.01).
Capsaicin- and vehicle-treated animals did not have different glucagon levels during the 150, 300 and
450 mg glucose infusion (F1, 12=0.65; F1, 6=3.24; F1, 10=1.91, respectively, NS).
Table 1 shows the basal levels of glucose, insulin and glucagon. No significant differences were
found between vehicle- and capsaicin-treated animals, except that basal glucose levels before 300 mg
i.v. glucose infusion started was significantly lower in capsaicin-treated animals (5.1F0.13 vs.
4.6F0.09 mM, pb0.01). However, since basal levels before the start of 150 mg or 450 mg i.v. glucose
infusion did not differ between vehicle- and capsaicin-treated animals, the significance is of this result
is unclear.Discussion
The main result of this study is that neonatal capsaicin-treated male Wistar rats showed a
diminished insulin response to an intravenous glucose infusion, while there was no difference in
glucose tolerance when 150, 300 or 450 mg glucose loads were infused. Glucagon levels did not
change during 150 and 450 mg glucose infusion in either deafferentated rats or their controls. There
were also no significant differences between capsaicin- and vehicle-treated animals considering
baseline plasma glucose and glucagon levels. This shows that a fine-tuned response to a glucose
infusion does not depend (solely) on capsaicin-sensitive sensory nerves, since capsaicin- and vehicle-
treated animals have similar glucose levels during an intravenous glucose infusion.
Our results are not in accordance with Karlsson et al. (1994) who found an improvement in glucose
tolerance in capsaicin-treated animals after a glucose challenge. This improvement was accompanied by
an enhancement of the early insulin response followed by lower insulin levels in capsaicin-treated
animals (Karlsson et al., 1994). Yet, in our study, capsaicin-treated animals exhibited a reduced insulin
response and there were no significant differences concerning the early insulin response. This
discrepancy between studies may be due to the fact that Karlsson et al. (1994) gave only one bolus
injection, whereas in our experiments the glucose infusion persisted for 30 min, this may partly have
blunted the effect of this increased early insulin response. Furthermore, Karlsson et al. (1994) used
female mice in their experiment which also might account for the observed differences with our results. It
is known that the oestrous cycle has profound effects on glucose homeostasis (Bailey and Matty, 1972).
Since the lower insulin response was accompanied with normal glucose tolerance in our capsaicin-
treated animals, results of the present experiments suggest that insulin sensitivity is increased. Results of
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tolerance after an OGTT. Earlier data of Zhou et al. (1990) and Koopmans et al. (1998) showed that after
capsaicin treatment insulin sensitivity indeed improves. Although with the present set up, it remains
unclear if the observed effects were due solely to increased insulin sensitivity, we do show that
capsaicin-sensitive nerves are involved in insulin secretion. Another explanation could be that capsaicin-
treated animals have an increased non-insulin-dependent glucose uptake, and as a result, a smaller
insulin response might be required to normalize blood glucose levels.
It is unlikely that factors modulating insulin sensitivity, like body weight and nutritional state, could
explain our results. It is known that a lower body weight can contribute to increased insulin sensitivity,
and a period of fasting can influence the response of insulin (Strubbe and Prins, 1986). In our
experiments, capsaicin treatment did not result in a different body weight compared to vehicle treatment.
No major differences concerning nutritional state were expected, since all animals were briefly food-
deprived for 3 h in the light period before the experiment started. We do not know if meal patterns
differed between capsaicin- and vehicle-treated animals, which might result in different fasting periods
before the experiment. However, such an explanation seems unlikely because this is usually associated
with increased glucose levels (Strubbe and Prins, 1986), which were not observed.
The reduced insulin response might be a result of modifications of the responsiveness of the B-cells in
capsaicin-treated animals. In vitro experiments on isolated islets exposed to capsaicin for several days
showed no effect on B-cell function. Karlsson et al. (1994) and Koopmans et al. (1998) did not find
altered islet secretory capacity in capsaicin-treated animals either. However, changes on islet level are
reported, since systemic capsaicin treatment led to an increase in both whole pancreatic and islet blood
flow, whereas fractional islet blood flow was decreased when compared with vehicle-treated rats
(Carlsson et al., 1996). This may have resulted in a different insulin output as well.
Altered functioning of the catecholamine system could also contribute to the differences in
glucohomeostatic mechanisms in capsaicin-treated animals as compared to controls. Catecholamines
limit glucose utilization, increase glucose production from the liver, inhibit insulin secretion and
stimulate glucagon secretion (Clutter et al., 1988). However, contradictory results are reported. Zhou et
al. (1990) found increased catecholamine levels in response to insulin-induced hypoglycemia after
neonatal capsaicin treatment, whereas Karlsson et al. (1994) did not find a significant effect on
catecholamine levels. We cannot exclude the contribution of altered catecholamine plasma levels to the
observed effects on insulin secretion. However, this explanation seems unlikely in view of the fact that
no major changes in catecholamine levels are generally observed during an intravenous glucose
tolerance test.
Glucagon is another insulin antagonistic hormone that might contribute to changes in plasma glucose
levels. However, no major differences were found in plasma glucagon levels and could therefore not
explain the present results. This result does not confirm the data of Karlsson et al. (1994), who
observed an increased plasma glucagon level 10 min after one single glucose injection in capsaicin-
treated animals. In addition, Karlsson et al. (1992) found a reduced glucagon response to a 2-deoxy-d-
glucose injection in capsaicin-treated rats, while insulin response was not affected. They concluded that
capsaicin-sensitive nerves are involved in the regulation of glucagon secretion. The present results
show that glucose homeostatic regulation via afferent nerves can also be modulated without glucagon
as mediator.
Niijima (1982) has shown that peripheral glucose-sensitive receptors exist in the liver. There are
many data pointing clearly at the importance of vagal afferents for the detection of glucose and for
E.H.E.M. van de Wall et al. / Life Sciences 77 (2005) 1283–12921290glucohomeostatic control (Zhou et al., 1990; Okazaki et al., 1993; Karlsson et al., 1994; Hevener et
al., 1997, 2000; Koopmans et al., 1998). However, conflicting data exist as well. Jackson et al.,
(1997, 2000) and Cardin et al. (2001) raised some questions about the importance of vagal afferents
for hypoglycemic detection, because they found that a functioning vagus nerve was not necessary
for a complete counterregulatory hormone response to moderate hypoglycemia. Since substantial
afferent innervation of the portohepatis ascends via the sympathetic nervous system, it could be that
hepatic glucosensors communicate with the brain via these afferents (Jackson et al., 2000). However,
it is as yet unclear whether the detection of hypoglycemic conditions is principally different from
hyperglycemic conditions. Our results suggest that detection of hyperglycemia does not depend
solely on capsaicin-sensitive nerves, since an infusion of different amounts of glucose results in a
normoglycemic response accompanied with a fine-tuned insulin response. Our data do show that
capsaicin-sensitive afferents are involved in insulin secretion in response to a certain glucose load.
The modified insulin response in capsaicin-treated animals might reflect a change in efferent
signalling as a result of the lack of afferent signalling; or, as suggested by Karlsson et al. (1994), it
might be that capsaicin-sensitive nerves display their effects locally, by intrinsic nerves of the
pancreas or by an afferent limb of a neural reflex regulation of glucose homeostasis. Since there are
strong indications that insulin sensitivity has changed after capsaicin treatment, we suggest the
hypothesis that capsaicin-sensitive sensory afferents are important in the (down) regulation of insulin
sensitivity.
In summary, our results suggest that capsaicin-sensitive afferents are not primarily involved in glucose
detection. We showed that neonatal capsaicin-treatment in male Wistar rats leads to a diminished insulin
response to an intravenous glucose infusion. It appears that capsaicin-sensitive sensory nerve fibers are
important in the regulation of glucose-stimulated insulin secretion and/or in the regulation of insulin
sensitivity. Glucagon levels do not differ between capsaicin- and vehicle-treated animals and could
therefore not explain the observed effects. We cannot exclude the possibility that present observations
are due to changes on a secondary level after neonatal capsaicin treatment such as non-insulin-dependent
glucose uptake, modified efferent output and/or local blood flow modifications on islet level. Since
modifications of insulin secretion (Karlsson et al., 1994; this study), as well as on glucagon secretion
(Karlsson et al., 1992) are reported, we suggest that capsaicin-sensitive sensory nerves might play a role
in the onset and development of pathologies in glucohomeostatic mechanisms.Acknowledgements
The authors would like to thank Jan Bruggink for his technical assistance during the experiments.References
Ahren, B., 2000. Autonomic regulation of islet hormone secretion—implications for health and disease. Diabetologia 43,
393–410.
Ahren, B., Taborsky Jr., G.J., Porte Jr., D., 1986. Neuropeptidergic versus cholinergic and adrenergic regulation of islet
hormone secretion. Diabetologia 29, 827–836.
Ahren, B., Larsson, H., Holst, J.J., 1997. Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in non-
insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology & Metabolism 82 (2), 473–478.
E.H.E.M. van de Wall et al. / Life Sciences 77 (2005) 1283–1292 1291Bailey, C.J., Matty, A.J., 1972. Glucose tolerance and plasma insulin of the rat in relation to the oestrous cycle and sex
hormones. Hormone and Metabolic Research 4 (4), 266–270.
Berthoud, H.R., Neuhuber, W.L., 2000. Functional and chemical anatomy of the afferent vagal system. Autonomic
Neuroscience 85, 1–17.
Burcelin, R., Katz, E.B., Charron, M.J., 1996. Molecular and cellular aspects of the glucagon receptor: role in diabetes and
metabolism. Diabetes Metabolism 22, 373–396.
Cardin, S., Jackson, P.A., Edgerton, D.S., Neal, D.W., Coffey, C.S., Cherrington, A.D., 2001. Effect of vagal cooling on
the counterregulatory response to hypoglycemia induced by a low dose of insulin in the conscious dog. Diabetes 50,
558–564.
Carlsson, P.O., Andersson, A., Jansson, L., 1996. Pancreatic islet blood flow in normal and obese-hyperglycemic (ob/ob) mice.
American Journal of Physiology 271, E990–E995.
Choi, S.B., Frontoni, S., Rossetti, L., 1991. Mechanism by which calcitonin gene-related peptide antagonizes insulin action in
vivo. American Journal of Physiology 260, E321–E325.
Clutter, W.E., Rizza, R.A., Gerich, J.E., Cryer, P.E., 1988. Regulation of glucose metabolism by sympathochromaffin
catecholamines. Diabetes Metababolism Research and Reviews 4, 1–15.
Guillot, E., Coste, A., Angel, I., 1996. Involvement of capsaicin-sensitive nerves in the regulation of glucose tolerance in
diabetic rats. Life Sciences 59, 969–977.
Hevener, A.L., Bergman, R.N., Donovan, C.M., 1997. Novel glucosensor for hypoglycemic detection localized to the portal
vein. Diabetes 46, 1521–1525.
Hevener, A.L., Bergman, R.N., Donovan, C.M., 2000. Portal vein afferents are critical for the sympathoadrenal response to
hypoglycemia. Diabetes 49, 8–12.
Holzer, P., 1991. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacological
Reviews 43, 143–201.
Jackson, P.A., Pagliassotti, M.J., Shiota, M., Neal, D.W., Cardin, S., Cherrington, A.D., 1997. Effects of vagal blockade on
the counterregulatory response to insulin-induced hypoglycemia in the dog. American Journal of Physiology 273,
E1178–E1188.
Jackson, P.A., Cardin, S., Coffey, C.S., Neal, D.W., Allen, E.J., Penaloza, A.R., Snead, W.L., Cherrington, A.D., 2000. Effect of
hepatic denervation on the counterregulatory response to insulin-induced hypoglycemia in the dog. American Journal of
Physiology 279 (6), E1249–E1257.
Jiang, G., Zhang, B.B., 2003. Glucagon and regulation of glucose metabolism. American Journal of Physiology 284,
E671–E678.
Karlsson, S., Sundler, F., Ahren, B., 1992. Neonatal capsaicin-treatment in mice: effects on pancreatic peptidergic nerves and 2-
deoxy-d-glucose-induced insulin and glucagon secretion. Journal of Autonomic Nervous System 39, 51–59.
Karlsson, S., Scheurink, A.J.W., Steffens, A.B., Ahren, B., 1994. Involvement of capsaicin-sensitive nerves in regulation of
insulin secretion and glucose tolerance in conscious mice. American Journal of Physiology 267, R1071–R1077.
Koopmans, S.J., Leighton, B., DeFronzo, R.A., 1998. Neonatal de-afferentation of capsaicin-sensitive sensory nerves increases
in vivo insulin sensitivity in conscious adult rats. Diabetologia 41, 813–820.
Kvist-Reimer, M., Sundler, F., Ahren, B., 2002. Effects of chemical sympathectomy by means of 6-hydroxydopamine on
insulin secretion and islet morphology in alloxan-diabetic mice. Cell and Tissue Research 307, 203–209.
Leighton, B., Foot, E.A., Cooper, G.G., King, J.M., 1989. Calcitonin gene-related peptide-1 (CGRP-1) is a potent regulator of
glycogen metabolism in rat skeletal muscle. FEBS Letters 249, 357–361.
Niijima, A., 1982. Glucose-sensitive afferent nerve fibres in the hepatic branch of the vagus nerve in the guinea-pig. Journal of
Physiology 332, 315–323.
Okazaki, H., Tanaka, K., Nagase, H., Inoue, S., 1993. Modulation of insulin secretion by hepatic vagotomy in cirrhotic rats.
Physiology and Behavior 53, 521–525.
Pettersson, M., Ahren, B., 1990. Calcitonin gene-related peptide inhibits insulin secretion studies on ion fluxes and cyclic AMP
in isolated rat islets. Diabetes Research 15, 9–14.
Pettersson, M., Ahren, B., Bottcher, G., Sundler, F., 1986. Calcitonin gene-related peptide: occurrence in pancreatic islets in the
mouse and the rat and inhibition of insulin secretion in the mouse. Endocrinology 119, 865–869.
Shimazu, T., 1996. Innervation of the liver and glucoregulation: roles of the hypothalamus and autonomic nerves. Nutrition 12,
65–66.
E.H.E.M. van de Wall et al. / Life Sciences 77 (2005) 1283–12921292Strubbe, J.H., Prins, A.J., 1986. Reduced insulin secretion after short-term food deprivation in rats plays a key role in the
adaptive interaction of glucose and free fatty acid utilization. Physiology and Behavior 37, 441–445.
Unger, R.H., 1985. Glucagon physiology and pathophysiology in the light of new advances. Diabetologia 28, 574–578.
Zhou, X.F., Jhamandas, K.H., Livett, B.G., 1990. Capsaicin-sensitive nerves are required for glucostasis but not for
catecholamine output during hypoglycemia in rats. American Journal of Physiology 258, E212–E219.
